Cargando…

White matter microstructure and sleep-wake disturbances in individuals at ultra-high risk of psychosis

AIM: White matter changes in individuals at ultra-high risk for psychosis (UHR) may be involved in the transition to psychosis. Sleep-wake disturbances commonly precede the first psychotic episode and predict development of psychosis. We examined associations between white matter microstructure and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rasmussen, Jesper Ø., Nordholm, Dorte, Glenthøj, Louise B., Jensen, Marie A., Garde, Anne H., Ragahava, Jayachandra M., Jennum, Poul J., Glenthøj, Birte Y., Nordentoft, Merete, Baandrup, Lone, Ebdrup, Bjørn H., Kristensen, Tina D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9649829/ https://www.ncbi.nlm.nih.gov/pubmed/36393990 http://dx.doi.org/10.3389/fnhum.2022.1029149

Ejemplares similares

Cannabidiol versus risperidone for treatment of recent-onset psychosis with comorbid cannabis use: study protocol for a randomized controlled clinical trial
por: Rasmussen, Jesper Østrup, et al.
Publicado: (2021)

Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial
por: Baandrup, Lone, et al.
Publicado: (2016)

Generalized neurocognitive impairment in individuals at ultra‐high risk for psychosis: The possible key role of slowed processing speed
por: Randers, Lasse, et al.
Publicado: (2021)

Widespread higher fractional anisotropy associates to better cognitive functions in individuals at ultra‐high risk for psychosis
por: Kristensen, Tina D., et al.
Publicado: (2019)

T18. EFFECTS OF COGNITIVE REMEDIATION ON WHITE MATTER IN INDIVIDUALS AT ULTRA-HIGH RISK FOR PSYCHOSIS – A RANDOMIZED, CONTROLLED CLINICAL TRIAL
por: Kristensen, Tina, et al.
Publicado: (2020)

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
por: Kristensen, Tina D., et al.
Publicado: (2020)

Effect of a dynamic lighting intervention on circadian rest-activity disturbances in cognitively impaired, older adults living in a nursing home: A proof-of-concept study
por: Baandrup, Lone, et al.
Publicado: (2021)

Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia: a randomized clinical trial - the SMART trial protocol
por: Baandrup, Lone, et al.
Publicado: (2011)

M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2023)

The effect of cognitive remediation in individuals at ultra-high risk for psychosis: a systematic review
por: Glenthøj, Louise Birkedal, et al.
Publicado: (2017)

T16. GLUTAMATERGIC CHANGES IN UHR
por: Wenneberg, Christina, et al.
Publicado: (2018)

Premorbid adjustment associates with cognitive and functional deficits in individuals at ultra-high risk of psychosis
por: Lundsgaard, Julie, et al.
Publicado: (2022)

Supplementary data for a focused review and meta-analysis of (1)H-MRS studies on cerebral glutamate and GABA levels in high-risk of psychosis states
por: Wenneberg, Christina, et al.
Publicado: (2019)

Self-perceived cognitive impairments in psychosis ultra-high risk individuals: associations with objective cognitive deficits and functioning
por: Glenthøj, Louise Birkedal, et al.
Publicado: (2020)

Treatment of sleep disturbances in trauma-affected refugees: Study protocol for a randomised controlled trial
por: Sandahl, Hinuga, et al.
Publicado: (2017)

T248. PSYCHOPATHOLOGY IN F2X.X-UNAFFECTED CO-TWINS AS A VULNERABILITY INDICATOR OF PSYCHOSIS
por: Hilker, Rikke, et al.
Publicado: (2018)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
por: Baandrup, Lone, et al.
Publicado: (2015)

Is an Early Age at Illness Onset in Schizophrenia Associated With Increased Genetic Susceptibility? Analysis of Data From the Nationwide Danish Twin Register
por: Hilker, Rikke, et al.
Publicado: (2017)

Treatment of antipsychotic-associated obesity with a GLP-1 receptor agonist—protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded intervention study: the TAO study protocol
por: Ishøy, Pelle L, et al.
Publicado: (2014)

Social cognition in patients at ultra-high risk for psychosis: What is the relation to social skills and functioning?
por: Glenthøj, Louise B., et al.
Publicado: (2016)

Brain Connectivity Studies in Schizophrenia: Unravelling the Effects of Antipsychotics
por: Nejad, Ayna B, et al.
Publicado: (2012)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers
por: Bojesen, Kirsten Borup, et al.
Publicado: (2018)

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis
por: Myken, Anders N, et al.
Publicado: (2022)

Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study
por: Jennum, Poul, et al.
Publicado: (2016)

Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial
por: Sandahl, Hinuga, et al.
Publicado: (2021)

Sleep impairments in refugees diagnosed with post-traumatic stress disorder: a polysomnographic and self-report study
por: Ansbjerg, Mia Beicher, et al.
Publicado: (2023)

Baseline measures of cerebral glutamate and GABA levels in individuals at ultrahigh risk for psychosis: Implications for clinical outcome after 12 months
por: Wenneberg, C., et al.
Publicado: (2020)

Volumetric Changes in the Basal Ganglia After Antipsychotic Monotherapy: A Systematic Review
por: Ebdrup, B.H, et al.
Publicado: (2013)

Accuracy of diagnostic classification algorithms using cognitive-, electrophysiological-, and neuroanatomical data in antipsychotic-naïve schizophrenia patients
por: Ebdrup, Bjørn H., et al.
Publicado: (2019)

Treatment response after 6 and 26 weeks is related to baseline glutamate and GABA levels in antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten B., et al.
Publicado: (2020)

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
por: Dahl, Anne Sofie A., et al.
Publicado: (2023)

Examination of gaze behaviour in social anxiety disorder using a virtual reality eye-tracking paradigm: protocol for a case–control study
por: Zeka, Fatime, et al.
Publicado: (2023)

Glucagon-like peptide-1 analogs against antipsychotic-induced weight gain: potential physiological benefits
por: Ebdrup, Bjørn H, et al.
Publicado: (2012)

Macroscale EEG characteristics in antipsychotic-naïve patients with first-episode psychosis and healthy controls
por: Dominicus, L. S., et al.
Publicado: (2023)

The Danish Schizophrenia Registry
por: Baandrup, Lone, et al.
Publicado: (2016)

Frontal D(2/3) Receptor Availability in Schizophrenia Patients Before and After Their First Antipsychotic Treatment: Relation to Cognitive Functions and Psychopathology
por: Nørbak-Emig, Henrik, et al.
Publicado: (2016)

O9.5. NORMALIZATION OF DISTURBANCES IN PREDICTION ERROR IS RELATED TO TREATMENT RESPONSE AND RELATED TO THALAMIC GLUTAMATE LEVELS IN NON-RESPONDERS
por: Tangmose, Karen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bt0adcrov0oeks465g2jfmkpvp